5-Chloro-6-hydroxy-1,3-benzoxazol-2(3H)-one
5-Chloro-6-hydroxy-1,3-benzoxazol-2(3H)-one structure
|
Common Name | 5-Chloro-6-hydroxy-1,3-benzoxazol-2(3H)-one | ||
|---|---|---|---|---|
| CAS Number | 1750-45-4 | Molecular Weight | 185.565 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C7H4ClNO3 | Melting Point | 240-242ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 5-Chloro-6-hydroxy-1,3-benzoxazol-2(3H)-one6-Hydroxy Chlorzoxazone is a metabolite of Chlorzoxazone (HY-B1462). Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort[1]. |
| Name | 6-Hydroxy Chlorzoxazone |
|---|---|
| Synonym | More Synonyms |
| Description | 6-Hydroxy Chlorzoxazone is a metabolite of Chlorzoxazone (HY-B1462). Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Melting Point | 240-242ºC |
| Molecular Formula | C7H4ClNO3 |
| Molecular Weight | 185.565 |
| Exact Mass | 184.987976 |
| PSA | 66.23000 |
| LogP | 1.59 |
| Index of Refraction | 1.651 |
| Storage condition | 2-8°C |
| Water Solubility | methanol: soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | DM5260000 |
| HS Code | 2934999090 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
CAS#:95-25-0| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Effect of commercially available green and black tea beverages on drug-metabolizing enzymes and oxidative stress in Wistar rats.
Food Chem. Toxicol. 70 , 120-7, (2014) The effect of commercially available green tea (GT) and black tea (BT) drinks on drug metabolizing enzymes (DME) and oxidative stress in rats was investigated. Male Wistar rats were fed a laboratory c... |
|
|
Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
Drug Metab. Dispos. 43 , 1408-16, (2015) The common marmoset (Callithrix jacchus), a small New World monkey, has the potential for use in human drug development due to its evolutionary closeness to humans. Four novel cDNAs, encoding cytochro... |
|
|
Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration.
Toxicol. Sci. 143(1) , 107-15, (2014) Acetaminophen (APAP) overdose is the most frequent cause of drug-induced acute liver failure. Schisandra sphenanthera is a traditional hepato-protective Chinese medicine and Schisandrol B (SolB) is on... |
| 5-chloro-6-hydroxy-3H-1,3-benzoxazol-2-one |
| 2(3H)-Benzoxazolone, 5-chloro-6-hydroxy- |
| 5-Chloro-6-hydroxy-1,3-benzoxazol-2(3H)-one |